SEC Company Response from MED-EMERG INTERNATIONAL INC (CIK 0001030179) — Nov 4, 2005

MED-EMERG INTERNATIONAL INC (CIK 0001030179)
Date: Nov. 4, 2005 · CIK: 0001030179 · Accession: 0001279569-05-000963

View on Edgar

AI Filing Summary & Sentiment

Date

October 12, 2005

Author

yours

Form

CORRESP

Company

MED-EMERG INTERNATIONAL INC (CIK 0001030179)

Letter

Ms. Keira Ino United States Securities and Exchange Commission Fifth Street, NW Washington, DC 20549

Dear Ms. Ino:

In response to the comments and questions posed by Mr. Jim Rosenberg, Senior Assistant Chief Accountant, in his letter of October 12, 2005, we advise that we concur with the comments made, regarding disclosure of the “Elimination of Deficit”. We will amend our 10K filing, accordingly.

With respect to the timing of our resubmissions, we are currently preparing our 10Q filing for the period ended September 30, 2005. In that filing, we will ensure that all disclosure modifications that have been made pursuant to the SEC’s 10K review will be reflected in the filing.

As soon as the 10Q filing for September 30, 2005, is submitted we will make all necessary changes and modifications to the 2004 10K and the 10Q filings for the periods ended March 31, 2005 and June 30, 2005. We anticipate that all of these filings will be complete and filed by November 30, 2005.

If you have questions please contact the writer at your earliest convenience at (905) 288-1003 or bdanis@med-emerg.com.

Sincerely
yours,
/s/William
J. Danis

Show Raw Text

CORRESP
1
filename1.htm

      Correspondence with the SEC

              6711
                MISSISSAUGA ROAD, SUITE 404

              MISSISSAUGA,
                ONTARIO, CANADA L5N 2W3

              PHONE:
                (905) 858-1368

              FAX:
                (905) 858-1399

              www.med-emerg.com

    October
      31, 2005

    Ms.
      Keira Ino

    United
      States Securities and Exchange Commission

    450
      Fifth Street, NW

    Washington,
      DC 20549

    Dear
      Ms. Ino:

    In
      response to the comments and questions posed by Mr. Jim Rosenberg, Senior
      Assistant Chief Accountant, in his letter of October 12, 2005, we advise that
      we
      concur with the comments made, regarding disclosure of the “Elimination of
      Deficit”. We will amend our 10K filing, accordingly.

    With
      respect to the timing of our resubmissions, we are currently preparing our
      10Q
      filing for the period ended September 30, 2005. In that filing, we will ensure
      that all disclosure modifications that have been made pursuant to the SEC’s 10K
      review will be reflected in the filing.

    As
      soon as the 10Q filing for September 30, 2005, is submitted we will make all
      necessary changes and modifications to the 2004 10K and the 10Q filings for
      the
      periods ended March 31, 2005 and June 30, 2005. We anticipate that all of these
      filings will be complete and filed by November 30, 2005.

    If
      you have questions please contact the writer at your earliest convenience at
      (905) 288-1003 or bdanis@med-emerg.com.

    Sincerely
      yours,

    /s/William
      J. Danis

    Chief
      Financial Officer

SecProbe.io